AmCad BioMed Corporation

TPEX:4188 Stock Report

Market Cap: NT$1.4b

AmCad BioMed Past Earnings Performance

Past criteria checks 0/6

AmCad BioMed's earnings have been declining at an average annual rate of -1.7%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been declining at an average rate of 4.1% per year.

Key information

-1.7%

Earnings growth rate

-1.6%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-4.1%
Return on equity-9.0%
Net Margin-69.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

Apr 19
Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Jan 04
AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Revenue & Expenses Breakdown
Beta

How AmCad BioMed makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4188 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2365-455144
30 Sep 2356-555149
30 Jun 2353-584853
31 Mar 2355-564853
31 Dec 2262-534854
30 Sep 2275-404852
30 Jun 2289-254949
31 Mar 2291-224850
31 Dec 2186-264651
30 Sep 2179-244447
30 Jun 2166-344549
31 Mar 2164-314648
31 Dec 2064-354949
30 Sep 2058-495553
30 Jun 2060-515754
31 Mar 2071-485956
31 Dec 1984-386058
30 Sep 1987-365959
30 Jun 1985-436062
31 Mar 1975-516065
31 Dec 1872-456267
30 Sep 1861-455764
30 Jun 1856-395457
31 Mar 1840-444752
31 Dec 1721-594144
30 Sep 1719-543641
30 Jun 1713-533340
31 Mar 1713-543538
31 Dec 1610-553238
30 Sep 167-583237
30 Jun 164-603037
31 Mar 160-582436
31 Dec 150-622836
30 Sep 150-592833
30 Jun 150-582932
31 Mar 150-552730
31 Dec 140-431926
30 Sep 140-401527
30 Jun 140-32925
31 Mar 140-25621
31 Dec 130-19319
30 Sep 130-13313
30 Jun 130-12312

Quality Earnings: 4188 is currently unprofitable.

Growing Profit Margin: 4188 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4188 is unprofitable, and losses have increased over the past 5 years at a rate of 1.7% per year.

Accelerating Growth: Unable to compare 4188's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4188 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-17.2%).


Return on Equity

High ROE: 4188 has a negative Return on Equity (-9.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.